chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient is experiencing sharp in the left arm/He is feeling pain and numbness from the area of the shot to the tips of his fingers; He is feeling pain and numbness from the area of the shot to the tips of his fingers; He is feeling pain and numbness from the area of the shot to the tips of his fingers; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 54-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Booster #1, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "The patient is experiencing sharp in the left arm/He is feeling pain and numbness from the area of the shot to the tips of his fingers"; PAIN IN EXTREMITY (non-serious), HYPOAESTHESIA (non-serious), outcome "unknown" and all described as "He is feeling pain and numbness from the area of the shot to the tips of his fingers".  Additional Information: After second Pfizer booster shot, the patient is experiencing sharp in the left arm and he is feeling pain and numbness from the area of the shot to the tips of his fingers.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
has anxiety and is very worried; Initial information was received on 10-Feb-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health-care professional.  This case involves 21 years old female patient who experienced has anxiety and is very worried while receiving vaccine rabies (hdc) vaccine [Imovax Rabies].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included rabies vaccine INACT (CHICK EMBRYO) (Rabavert) for Prophylactic vaccination.  On 26-Dec-2022, the patient received a 4 dose of suspect rabies (hdc) vaccine lot PMC4928125251 via intramuscular route in unknown administration site for Immunisation.  On an unknown date the patient developed a non-serious event of has anxiety and is very worried (anxiety) (unknown latency) following the administration of rabies (hdc) vaccine.  Action taken with rabies vaccine (Imovax Rabies) was not applicable.  It was not reported if the patient received a corrective treatment for the event (has anxiety and is very worried).  At time of reporting, the outcome was Unknown for the event has anxiety and is very worried.
Night of second dose, I had involuntary twitching in my arms and legs throughout the night that caused me to not be able to sleep. On 3/15, I began to feel pain on my skin. I developed a shingles rash on 3/16. I was diagnosed with shingles on 3/18.
Initial unsolicited report received from a pharmacist on 09 December 2015. This case involves a 67-year-old female patient who was vaccinated with a dose of FLUZONE HD (batch number, expiry date, dose, were not reported) intramuscularly in left deltoid on 04 November 2015. Illness at time of vaccination reported as no and pre-existing physician diagnosed allergies, birth defects, medical conditions reported as none. Concomitant medications were not reported. On 04 November 2015, same day following the vaccination, the patient had developed stiffness and soreness in the arm. It was reported that symptoms were improving, but still present. No lab investigations were done and corrective treatment was not reported. The patient was not recovered from the event. List of documents held by sender: none.
CHEST PAINS AND SHORTNESS OF BREATH MANIFESTED AFTER 2ND SERIES WAS GIVEN. IT WAS SEVER ENOUGH THAT MY PRIMARY CARE PROVIDER ISSUED A PHYSICAL TRAINING (PT) WAIVER DURING THIS PERIOD.
Moderna COVID-19 Vaccine EUA Pain in upper arm at ejection site & slight redness. Started same day  some residual (5+  days) Compete exhaustion with severe headache. Started day after on 6-4-2021 some residual still occurring 6/9/2021 (6 + days) Nausea. Started day after on 6-4-2021.  Some traces on 6-5-2021 (2 days) Cough. Started three days after on 6-5-2021 some residual still occurring (5+ days) Feeling of heaviness in chest. Started on 6-5-2021. (lasted 1/2 day)
Achiness, fatigue, fever, nausea, headache, loss of appetite, arm soreness Tylenol, Zoltan, rest, stay home from work 3 days
Soreness began within 4-6 hrs - worsened 24 hr period. 24 hrs after shots I experienced chills and fever of 101.9 degrees. Pain arm was severe. Improvement after 48 hrs.
CoughWheeze, NauseaVomiting, fatigue, shortness of breath, sore throat Narrative:
3 days p/vax red rash in patches on abd, back & arm;rash resembled rubella lasted approx 15hr;pt taken to MD rash gone couldn't dx;ears, throat, eyes, teeth all nl;7 days p/vax low grade fever (101) lasted 2 1/2 days;called MD
Changes in mentration- heavy bleeding outside of normal cycle by put to 5 days even while in hormonal birth control pill. Irregular cycles. For last 3months
Initial date of vaccine sore arm for two days.  Approximately 8 days after injection site rash, swelling, itching, hot to touch.  I believe I am experiencing covid arm?  Which I hope will resolve itself in a day or two.
itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product usage were not provided. Treatment details were also not provided.   Reporter did not allow further contact
Received the first dose of the Pfizer vaccine on 26Feb2021 and on 26Mar2021 received a Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received the first dose of the Pfizer vaccine on 26Feb2021 and on 26Mar2021 received a Moderna vaccine) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, BUDESONIDE, CALCIUM, VITAMIN D3, LOSARTAN, METOPROLOL, OMEPRAZOLE, SERTRALINE and TRAZODONE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received the first dose of the Pfizer vaccine on 26Feb2021 and on 26Mar2021 received a Moderna vaccine). On 26-Mar-2021, INTERCHANGE OF VACCINE PRODUCTS (Received the first dose of the Pfizer vaccine on 26Feb2021 and on 26Mar2021 received a Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was calling to report that a patient received their first dose of the Pfizer vaccine on 26-Feb-2021 and on 26-Mar-2021, the patient received a Moderna vaccine.  Concomitant medication used also included 25 mg of sertraline for an unknown indication.  No treatment information was provided.
Swelling of lips after 15 minute wait period; Diphenhydramine given; monitored for 75 minutes before discharge
Patient received vaccine on 12/7/2022.  On 12/8/2022, patient developed nausea and anorexia. Vital signs reported at that time: T 97.8 P 73 R 17 BP 130/78  Pox 98%. Elevated temperature T101.2,  BP 144/78 , one episode of diarrhea reported prior to dialysis. Tylenol, Imodium  administered. Nausea resolved. Patient later attended dialysis where fever and hypotension were reported, BP 80/54, bolus administered without improvement. Patient subsequently transferred to the hospital. Patient admitted to the hospital for 4 days. Hospitalization attributed to depleted volume status due to poor PO intake.
Day of I have a bit of soreness in my arm but nothing else. Yesterday, I experienced aching in my knees and joints I have fractured in the passed. I have had nausea and headaches. My fever peeked at 101.2. I had a little swelling and soreness at injection site. Today, my fever broke early this morning. All symptoms the same as yesterday. I have a 4? diameter Lump at injection site. Possible infection according to Urgent Care Physician. I was given antibiotics. and steroid cream to help with  itching and burning sensation.
Dizziness, weakness, orthostatic B/P- ? dehydration sent to hospital ER
Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse Event; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse Event). At the time of the report, UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant follow-up appended: Patient details (Age group) was added.
vaccinated with Pediarix in left thigh 1/20/04. Parents notices lump at that site 3/2/04, and were seen (thought to be calcified hematoma. ) Lump persisted so x-rayed on 4/21/04 and MRI done 5/25 because of increased size. Required surgical excision biopsy 6/2/04 which showed accrotizing granulomatous inflammation with no evidence of acid-fast fungal or bacterial organisms.
Patient complained of knot in arm at site of injection and swelling in the upper arm extending down towards the hand. Patient states it is sore and warm to the touch throughout arm.
pt recv vax 16FEB96 & pt began to devel a cluster of lesions around the inj site;pt devel a full-blown cellulitis @ the site of the inj & by 28FEB98 pt had approx 15-17 lesions distributed gen over body;28FEB98 pt adm to hosp x 3 days;
Patient receives the appropriate medication(s), safely administered during the pre-procedure period. The patient participates in the decisions related to their procedure plan of care. The patient demonstrates knowledge of the expected responses to the operative or invasive procedure.   Corona virus screening: Patient denies  any contact with a person who is under investigation for corona virus. Patient denies fever and  respiratory symptoms.   Belongings:  Pt belongings bag including clothes, shoes, , cell phone, are stored in designated area.  Pt was instructed not to bring any valuables.Patient was encouraged to give valuables to family at time of admission.  Patient denies any other valuables in bag.    Medications:none   Antibiotics to be administered during surgery were spiked, primed and labeled (with date and time spiked per anesthesia directive).  They were hung on the gurney IV pole, unattached to the primary line, and handed off to the circulator RN.    LAB:      Note Details  Author (R.N.) File Time 8/24/2023 11:41 AM Author Type REGISTERED NURSE Status Signed Last Editor (R.N.) Specialty GENERAL, OTHER Admit Date 8/24/2023  Admission (Discharged) on 8/24/2023  Admission (Discharged) on 8/24/2023   Detailed Report  Note shared with patient Care Timeline  08/24   PARACENTESIS ABDOMINAL, THERAPEUTIC    Discharged 1503
Temperature of 101.5 -- chills - headaches - shoulder & neck pain - muscle pain - fatigue - vomiting Feeling better on day 2
It effected "my" blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Mar2021 at 10:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 01Mar2021 at 11:30, the patient's blood pressure was effected and kidney lab reports which were taken approximately 2 hours after vaccination. Blood pressure returned to normal a day later and was awaiting kidney lab/blood test in 3 weeks. It was also reported that this was not a life endangering or serious effect, but might need to be identified. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 01Mar2021, the patient underwent blood pressure test, kidney function test/blood test and the results were not provided and blood pressure returned to normal a day later on 02Mar2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blood pressure was effected was resolved on 02Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Redness and pain at site of injection - also redness and pain approximately 2 inches from site of injection.
Threw up violently 6am after having takeout both breakfast and lunch day before.  Terrible pain in left eye so went to urgent care as soon as could get in that day.  Tested negative for Covid and no obvious eye issues. Saw my eye doctor next day with lessening pain. Said eye ok.  Have been fine since.
HE CALLED ME ON  MAY 6, 2021 REPORTED THAT HE IS HAVING SEVERE NAUSEA, MUSCLE ACHES, THROWING UP. NO DIZZINESS.  BECUASE OF MUSCLE ACHES I ASKED HIM TO STOP TAKING ATORVASTATIN NEED TO CONTACT MD ABOUT THE FURTHER CHECKUP AND EVALUATION.
Noticed large rash on left upper arm on Feb. 21 about 10 pm.  On Feb. 22 still a rash but doesn't seem to be any larger. Minor warm feel to the area.   Haven't really done anything to treat other then some Neosporin ointment.
* Final Report * Patient presented to influenza mass vaccination site at 0829.  Negative Screening - okay to give vaccine.    0830: Vaccine Administered.  Patient sat down in chair due to 'feeling dizzy' 0831: Patient Syncopal Episode. RN Alerted. Provider entered room, proceeded to assess patient.  Code was initiated due to no patient response.  Patient had pulse and respirations Within 30 seconds, patient was responsive to verbal stimuli. Code Cancelled. No vital signs machine on deck, runner sent. Patient AOx4 - stated no SOB, no trouble breathing. Patient has pale lips.  0836: Nurse remains at chairside, Patient reported no shortness of breath. Reports feeling better. Patient states that he 'has a 50-50 chance to pass out after getting any vaccine.' Patient educated to let staff know this prior to getting another vaccine.  0839: Nurse leaves bedside. Calls report to Dr. Plan for vital signs as soon as the machine arrives and again 30 minutes post-vaccine.   0845: Vitals: 131/81, R 17, SpO2 99%, HR 76, T 98.5.  0910: Vitals: 127/76, R 16, SpO2 99%, HR 79, T 98.9 0915: Patient released back to workspace.  ER precautions given.
Chills, temperature of 101, pain at joints and skin, severe pain at injection site.  I was far more sick from this than when I had covid late last year.
Janssen COVID-19 Vaccine EUA Patient had her Johnson and Johnson vaccine on March 10th.  About 2 weeks after she started feeling achy all over like she over did something.  She had diffuse arthralgias in both shoulders and also both knees, left knee worse.  She also developed left groin/hip discomfort and arthralgias.  Symptoms have been persistent.  She denies any trauma or overuse.  No DJD symptoms before onset as above.
Hives all over body including face.  Some of the hives go away and others reappear even though it's a week after the shot.  Benadryl doesn't help and the hives itch badly.  The injection site is itchy, scabbed over and swollen even a week later.
FDA AUTHORIZED  BIVALENT BOOSTER ON 08/31/2022 PT RECEIVED THE 4TH DOSE AS ERROR SINCE MONOVALEN IS OUT OF CLINICAL
Hepatitis A Vaccine, Nose bleeds suddenly, has never had a nose bleed before, has had 2 within an hour lasting 10-15 minutes each
Booster; experienced their 6th day of a Migraine headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 60 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2), for COVID-19 Immunization; Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster"; MIGRAINE (non-serious), outcome "unknown", described as "experienced their 6th day of a Migraine headache".  Additional details: Reporter and his 60 year old mother (patient) received Pfizer Covid-19 Booster Vaccine and both experienced their 6th day of a migraine headache. Reporter enquired how long it lasts. Reporter stated that he is missing work and commented not to get the booster, it doesn't work against Omicron.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
R sided facial swelling, R sided parotid gland enlargement.  Vaccine administered on R arm as per patient.
had the shingles; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient herself/himself. The age at vaccination was not reported. Patient had the Shingles shot and 3 days later got shingles. The patient reported to stop lying to the people
After 2nd dose of Pfizer Pain in right arm and swelling  under arm. Tender
The morning of 10/15/11, pt noticed redness, pain, swelling at injection site. Took TYLENOL. Pain worsened & pt went to ER the afternoon of 10/15/11. They diagnosed her with cellulitis & gave prescription for KEFLEX 500 mg PO BID. 10/17/11 rash was spreading to axillary area. She went to her PCP who suggested she go back to ER.
Headache and fatigue Monday night, got up went to work Tuesday, arm painful, swollen armpit, body aches, leg cramps, achy body muscles all over, by noon start temp rising took Tylenol, chills,  7pm  fever 99.6 , 8pm  101.2 called in sick Wednesday fever 99.6, by 3pm felt better notified employer
Case number PHEH2014US019417 is an initial spontaneous report received from a consumer on 25 SEP 2014. This report refers to a 51 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: not reported0 intramuscularly on 14 SEP 2014. On the same day after vaccination, she experienced pain and swelling in her arm. It ws reported that her arm was very sore and she could not use it. She tried  heat, ice, Aspirin and ibuprofen, but nothing helped her. The events outcome was unknown. The seriousness and causality were not reported.
This spontaneous report as received from a healthcare worker and nurse refers to unspecified patients. Medical history and concomitant medications were unknown. The nurse reported that improperly stored doses of PNEUMOVAX23 (single dose vials) were given to unspecified patients on unspecified dates (incorrect product storage). NO adverse experiences were reported. No product quality complaint (PQC) was involved. The outcome was unknown. The case is also related to 1507USA00113, 1507USA001114 and 1507USA001115 (same reporter link). Additional information has been requested.
Vaccine received 8 pm Friday. No reaction or side effects on that evening. Next day, around 11 am, leg muscle pain started, then fatigue and severe headache. All that lasted till late evening, took ibuprofen before bed and all gone by Sunday morning.
pt recv vax 23APR97 & the following day pt exp swelling from above the shoulder to elbow, (described as) hot, red & tender;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 21-OCT-2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of shingles, or severe herpes zoster. On or about 20-FEB-2015, the patient was treated by a physician for the onset of rash, which was diagnosed as shingles. The patient was prescribed VALTREX (valacyclovir hydrochloride) for management of his painful symptoms and chronic pain. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient suffered and continues to suffer painful and ongoing injuries and damages, and required and continues to require extensive medical care and treatment. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 15-MAR-2016, the patient was vaccinated with improperly stored VARIVAX (Merck) lot # L011084 with Expiration Date of 01-APR-2017 (dose, dose number, vaccination site and route not provided), which was exposed to the following temperature: 18.71 F for 15.5 hours. The previous temperature excursions were 15.71F for 36 hours and 29.85 F for 24 hours. No adverse symptoms reported. This is one of several reports received from the same source. Additional information has been requested.
numbness down whole arm, inability to use arm & squeeze hand-started to improve p/3 wks; went to MD & no treatment;
On 5/6/03 reported by mother that child on 5/3/03 a red rash on abdomen, neck, face and back-had no fever. Child had a cough, was tired and fussy. Tylenol had been given since being vaccinated.
Injection site red, warm, firm. Child was running fever 101 - 103. Ibuprofen given - KEFLEX rx'd.